rss
Evid Based Nurs 12:45 doi:10.1136/ebn.12.2.45
  • Treatment

Review: weight-reducing agents improve glycaemic control and reduce progression to diabetes

S Czernichow

Dr S Czernichow, Unite de Recherche en Nutrition Humaine, Bobigny, France; s.czernichow@uren.smbh.univ-paris13.fr

QUESTION

How do weight-reducing agents affect glycaemic parameters and risk of type 2 diabetes in predisposed individuals?

REVIEW SCOPE

Included studies were randomised, double-blind, placebo controlled trials (RCTs) that evaluated the effects of weight-reducing agents (eg, orlistat, sibutramine, and rimonabant) on fasting glucose or glycated haemoglobin (HbA1c) concentrations and had a duration of ⩾1 year. Studies of mixed populations were excluded. Outcomes included weight loss, fasting glucose and HbA1c concentrations, and diabetes.

REVIEW METHODS

Medline was searched from …

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article